Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.
The price of 10x Genomics Inc (NASDAQ: TXG) closed at $27.25 in the last session, down -0.84% from day before closing price of $27.48. In other words, the price has decreased by -$0.84 from its previous closing price. On the day, 1.39 million shares were traded. TXG stock price reached its highest trading level at $28.25 during the session, while it also had its lowest trading level at $27.17.
Ratios:
We take a closer look at TXG’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 4.45 and its Current Ratio is at 5.22. In the meantime, Its Debt-to-Equity ratio is 0.13 whereas as Long-Term Debt/Eq ratio is at 0.11.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, TD Cowen on May 01, 2024, Downgraded its rating to Hold and sets its target price to $32 from $57 previously.
On December 14, 2023, Guggenheim started tracking the stock assigning a Buy rating and target price of $60.
On December 13, 2023, Wolfe Research started tracking the stock assigning a Outperform rating and target price of $55.Wolfe Research initiated its Outperform rating on December 13, 2023, with a $55 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Mar 04 ’24 when Saxonov Serge sold 4,660 shares for $44.00 per share. The transaction valued at 205,021 led to the insider holds 842,900 shares of the business.
Saxonov Serge sold 2,821 shares of TXG for $130,737 on Feb 22 ’24. The Chief Executive Officer now owns 847,560 shares after completing the transaction at $46.34 per share. On Feb 22 ’24, another insider, Hindson Benjamin J., who serves as the insider of the company, sold 2,613 shares for $46.34 each. As a result, the insider received 121,098 and left with 283,059 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, TXG now has a Market Capitalization of 3289592832 and an Enterprise Value of 2982416640. For the stock, the TTM Price-to-Sale (P/S) ratio is 5.22 while its Price-to-Book (P/B) ratio in mrq is 4.54. Its current Enterprise Value per Revenue stands at 4.768 whereas that against EBITDA is -18.171.
Stock Price History:
Over the past 52 weeks, TXG has reached a high of $63.57, while it has fallen to a 52-week low of $24.60. The 50-Day Moving Average of the stock is -24.21%, while the 200-Day Moving Average is calculated to be -38.06%.
Shares Statistics:
According to the various share statistics, TXG traded on average about 1.59M shares per day over the past 3-months and 2302840 shares per day over the past 10 days. A total of 105.04M shares are outstanding, with a floating share count of 98.53M. Insiders hold about 17.69% of the company’s shares, while institutions hold 81.36% stake in the company. Shares short for TXG as of 1713139200 were 8870437 with a Short Ratio of 5.59, compared to 1710460800 on 8578557. Therefore, it implies a Short% of Shares Outstanding of 8870437 and a Short% of Float of 9.7399995.
